ArticleIn vivo (Athens, Greece)

Management of Severe Abemaciclib-induced Liver Dysfunction: Feasibility of Switching to Palbociclib.

Shinya Takada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.